Exenatide Pivotal Studies
Background Therapy
AMIGO 1: Metformin
AMIGO 2: Sulfonylurea
AMIGO 3: Metformin + Sulfonylurea
Primary Objectives
Glucose control (A1C)
Safety and tolerability
Secondary Objectives
Fasting and postprandial glucose
Body weight
Previous slide
Next slide
Back to first slide
View graphic version